跳至主要内容
临床试验/NCT06258499
NCT06258499撤回2 期

A Multicenter, Randomized, Controlled, Blinded Study of the Safety and Efficacy of Bone Healing Accelerant Versus Autologous Bone Grafting in Subjects Undergoing Hindfoot or Ankle Arthrodesis and Who Require Supplementary Grafting

Carmell Therapeutics Corporation0 个研究点开始时间: 2024年3月1日最近更新:
适应症
干预措施

试验速览

阶段
2 期
状态
撤回
主要终点
Successful Radiographic Fusion

研究概览

简要总结

This study is being conducted to demonstrate the safety and effectiveness of Bone Healing Accelerant (BHA) product when applied to the joint space of the ankle of hindfoot (the section of the foot immediately below the ankle joint) during fusion surgery. It is hypothesized that by 6 months, the number of subjects with successful bone fusion will be greater in the BHA-treated group compared to subjects treated with standard of care alone.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patient has pain with weight-bearing in the joint(s) below that, in the opinion of the Investigator, warrants arthrodesis:
  • •Tibiotalar (ankle)
  • •Talocalcaneal (subtalar)
  • •Talonavicular
  • •Calcaneocuboid
  • •Double hindfoot (e.g., talonavicular and talocalcaneal joints)
  • •Triple hindfoot (subtalar, talonavicular and calcaneocuboid joints
  • •Joint space(s) can, in the opinion of the Investigator, be adequately filled with no more than 9 cc of graft material (BHA or ABG)
  • •Each fused joint can be adequately compressed and rigidly stabilized with plates, screws, staples or a combination thereof. External fixation, percutaneous Kirschner wires or intramedullary rods may not be used.
  • •Patient is willing and able to comply with all study requirements including all postoperative clinical and radiographic evaluations.
  • •If patient is a woman of childbearing bearing potential (not post-menopausal for 12 months or surgically sterile), patient has a urine pregnancy test with a negative result at screening and on the day of surgery, prior to the procedure. These trial participants must commit to adequate birth control through the 52-week follow-up

排除标准

  • •Skeletally immature patients (i.e., radiographic evidence of open physes), regardless of age
  • •Bone deficit, defect or void requiring a structural graft
  • •Condition requiring intramedullary nailing or external fixation for the arthrodesis
  • •Condition requiring osteotomy or fusion of any midfoot joints.
  • •Prior arthroplasty, arthrodesis, major surgical repair or reconstruction of the index ankle or hindfoot joints.

研究组 & 干预措施

BHA

Experimental

Subjects treated with BHA + standard of care

干预措施: BHA (Combination Product)

Control

No Intervention

Subjects treated as per standard of care

结局指标

主要结局

Successful Radiographic Fusion

时间窗: 24 weeks

Greater than or equal to 50% bone bridging across joint space for the full complement of joints fused as determined by CT in the absence of secondary surgical or nonsurgical interventions intended to promote fusion.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

相似试验